Compare Immunovant Inc. Common Stock (IMVT) vs Virtu Financial Inc. Class A Common Stock (VIRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Virtu Financial Inc. Class A Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.36 (market cap $6.25B), while Virtu Financial Inc. Class A Common Stock trades at $57.04 (market cap $5.10B). The key difference: Immunovant Inc. Common Stock is the larger of the two by market cap, and Virtu Financial Inc. Class A Common Stock pays a 1.66% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and Virtu Financial Inc. Class A Common Stock for 1 Days on average.
| IMVT | VIRT | |
|---|---|---|
Market Cap | $6.25B | $5.10B |
Volume | 1,755,411 | 871,626 |
Sector | Health | Financials |
52-Week High | $44.96 | $67.93 |
52-Week Low | $17.03 | $32.53 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.35B | $14.81B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Virtu Financial Inc. Class A Common Stock
Virtu Financial provides technology-enabled market-making and execution services. Its platforms help institutional, retail, and other market participants trade across global financial markets.
Read more on VIRT →
